Effects of a-1 antitrypsin augmentation therapy and a-1 antitrypsin deficiency in pneumococcal pneumonia in mice
L. Ostermann (Hannover, Germany), R. Maus (Hannover, Germany), J. Stolper (Hannover, Germany), L. Schütte (Hannover, Germany), F. Hollwedel (Hannover, Germany), S. Janciauskiene (Hannover, Germany), C. Mueller (Worcester, United States of America), T. Welte (Hannover, Germany), U. Maus (Hannover, Germany)
Source: International Congress 2019 – Advances in COPD pharmacology
Session: Advances in COPD pharmacology
Session type: Poster Discussion
Number: 2033
Disease area: Airway diseases, Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Ostermann (Hannover, Germany), R. Maus (Hannover, Germany), J. Stolper (Hannover, Germany), L. Schütte (Hannover, Germany), F. Hollwedel (Hannover, Germany), S. Janciauskiene (Hannover, Germany), C. Mueller (Worcester, United States of America), T. Welte (Hannover, Germany), U. Maus (Hannover, Germany). Effects of a-1 antitrypsin augmentation therapy and a-1 antitrypsin deficiency in pneumococcal pneumonia in mice. 2033
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: